Product References
KAT7-mediated CANX (calnexin) crotonylation regulates leucine-stimulated MTORC1 activity.
Autophagy
Yan G,Li X,Zheng Z,Gao W,Chen C,Wang X,Cheng Z,Yu J,Zou G,Farooq MZ,Zhu X,Zhu W,Zhong Q,Yan X
Thu Dec 01 00:00:00 UTC 2022
HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
Life sciences
Wang X,Feng Q,Yu H,Zhou X,Shan C,Zhang Q,Liu S
Sun Mar 15 00:00:00 UTC 2020
HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
Life sciences
Wang X,Feng Q,Yu H,Zhou X,Shan C,Zhang Q,Liu S
Sun Mar 15 00:00:00 UTC 2020
Germacrone Regulates HBXIP-Mediated Cell Cycle, Apoptosis and Promotes the Formation of Autophagosomes to Inhibit the Proliferation of Gastric Cancer Cells.
Frontiers in oncology
Fang X,Tan T,Gao B,Zhao Y,Liu T,Xia Q
Sat Nov 28 00:00:00 UTC 2020
HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Pathology, research and practice
Zhou X,Wang X,Duan J,Sun W,Chen Z,Li Q,Ou Z,Jiang G,Ren X,Liu S
Fri Feb 01 00:00:00 UTC 2019
HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Pathology, research and practice
Zhou X,Wang X,Duan J,Sun W,Chen Z,Li Q,Ou Z,Jiang G,Ren X,Liu S
Fri Feb 01 00:00:00 UTC 2019
Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of Human Hepatoblastoma Cells.
Molecules (Basel, Switzerland)
Wang L,Liu M,Yin F,Wang Y,Li X,Wu Y,Ye C,Liu J
Wed Sep 18 00:00:00 UTC 2019
Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
American journal of cancer research
Xia H,Ma L,Li J,Bai H,Wang D
Thu Oct 01 00:00:00 UTC 2020
Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
American journal of cancer research
Xia H,Ma L,Li J,Bai H,Wang D
Thu Oct 01 00:00:00 UTC 2020
Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
American journal of cancer research
Xia H,Ma L,Li J,Bai H,Wang D
Thu Oct 01 00:00:00 UTC 2020
Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
American journal of cancer research
Xia H,Ma L,Li J,Bai H,Wang D
Thu Oct 01 00:00:00 UTC 2020
HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
Journal of ovarian research
Wang Y,Sun J,Li N,Che S,Jin T,Liu S,Lin Z
Fri Apr 07 00:00:00 UTC 2017
HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
Journal of ovarian research
Wang Y,Sun J,Li N,Che S,Jin T,Liu S,Lin Z
Fri Apr 07 00:00:00 UTC 2017
HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
Journal of ovarian research
Wang Y,Sun J,Li N,Che S,Jin T,Liu S,Lin Z
Fri Apr 07 00:00:00 UTC 2017
HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Wang Y,Li N,Che S,Jin T,Piao J,Liu S,Lin Z
Sat Jul 01 00:00:00 UTC 2017
HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Wang Y,Li N,Che S,Jin T,Piao J,Liu S,Lin Z
Sat Jul 01 00:00:00 UTC 2017
HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Wang Y,Li N,Che S,Jin T,Piao J,Liu S,Lin Z
Sat Jul 01 00:00:00 UTC 2017
HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Wang Y,Li N,Che S,Jin T,Piao J,Liu S,Lin Z
Sat Jul 01 00:00:00 UTC 2017
HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Wang Y,Li N,Che S,Jin T,Piao J,Liu S,Lin Z
Sat Jul 01 00:00:00 UTC 2017
The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
International journal of oncology
Xu F,Zhu X,Han T,You X,Liu F,Ye L,Zhang X,Wang X,Yao Y
Tue Jul 01 00:00:00 UTC 2014
The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
International journal of oncology
Xu F,Zhu X,Han T,You X,Liu F,Ye L,Zhang X,Wang X,Yao Y
Tue Jul 01 00:00:00 UTC 2014
The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
Cancer letters
Xu F,You X,Liu F,Shen X,Yao Y,Ye L,Zhang X
Sat Jun 01 00:00:00 UTC 2013
The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
Cancer letters
Xu F,You X,Liu F,Shen X,Yao Y,Ye L,Zhang X
Sat Jun 01 00:00:00 UTC 2013
The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
Cancer letters
Xu F,You X,Liu F,Shen X,Yao Y,Ye L,Zhang X
Sat Jun 01 00:00:00 UTC 2013
The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
Cancer letters
Xu F,You X,Liu F,Shen X,Yao Y,Ye L,Zhang X
Sat Jun 01 00:00:00 UTC 2013
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
The Journal of biological chemistry
Liu S,Li L,Zhang Y,Zhang Y,Zhao Y,You X,Lin Z,Zhang X,Ye L
Fri Aug 31 00:00:00 UTC 2012
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
The Journal of biological chemistry
Liu S,Li L,Zhang Y,Zhang Y,Zhao Y,You X,Lin Z,Zhang X,Ye L
Fri Aug 31 00:00:00 UTC 2012
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
The Journal of biological chemistry
Liu S,Li L,Zhang Y,Zhang Y,Zhao Y,You X,Lin Z,Zhang X,Ye L
Fri Aug 31 00:00:00 UTC 2012
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
The Journal of biological chemistry
Liu S,Li L,Zhang Y,Zhang Y,Zhao Y,You X,Lin Z,Zhang X,Ye L
Fri Aug 31 00:00:00 UTC 2012
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
The Journal of biological chemistry
Liu S,Li L,Zhang Y,Zhang Y,Zhao Y,You X,Lin Z,Zhang X,Ye L
Fri Aug 31 00:00:00 UTC 2012
The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
The Journal of biological chemistry
Liu S,Li L,Zhang Y,Zhang Y,Zhao Y,You X,Lin Z,Zhang X,Ye L
Fri Aug 31 00:00:00 UTC 2012